• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬菌体 phiIPLA-RODI 的包封策略。

Strategies to Encapsulate the Bacteriophage phiIPLA-RODI.

机构信息

Instituto de Productos Lácteos de Asturias (IPLA-CSIC), Paseo Río Linares s/n, 33300 Villaviciosa, Spain.

Nanovex Biotechnologies S.L., Parque Tecnológico de Asturias, CEEI, 33428 Llanera, Spain.

出版信息

Viruses. 2018 Sep 13;10(9):495. doi: 10.3390/v10090495.

DOI:10.3390/v10090495
PMID:30217072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6163856/
Abstract

The antimicrobial properties of bacteriophages make them suitable food biopreservatives. However, such applications require the development of strategies that ensure stability of the phage particles during food processing. In this study, we assess the protective effect of encapsulation of the bacteriophage phiIPLA-RODI in three kinds of nanovesicles (niosomes, liposomes, and transfersomes). All these systems allowed the successful encapsulation of phage phiIPLA-RODI with an efficiency ranged between 62% and 98%, regardless of the concentration of components (like phospholipids and surfactants) used for vesicle formation. Only niosomes containing 30 mg/mL of surfactants exhibited a slightly lower percentage of encapsulation. Regarding particle size distribution, the values determined for niosomes, liposomes, and transfersomes were 0.82 ± 0.09 µm, 1.66 ± 0.21 µm, and 0.55 ± 0.06 µm, respectively. Importantly, bacteriophage infectivity was maintained during storage for 6 months at 4 °C for all three types of nanovesicles, with the exception of liposomes containing a low concentration of components. In addition, we observed that niosomes partially protected the phage particles from low pH. Thus, while free phiIPLA-RODI was not detectable after 60 min of incubation at pH 4.5, titer of phage encapsulated in niosomes decreased only 2 log units. Overall, our results show that encapsulation represents an appropriate procedure to improve stability and, consequently, antimicrobial efficacy of phages for application in the food processing industry.

摘要

噬菌体的抗菌特性使它们成为合适的食品生物防腐剂。然而,此类应用需要开发确保噬菌体颗粒在食品加工过程中稳定性的策略。在这项研究中,我们评估了将噬菌体 phiIPLA-RODI 封装在三种纳米囊泡(脂质体、转脂体和非离子型脂质体)中的保护效果。所有这些系统都成功地将噬菌体 phiIPLA-RODI 封装,封装效率在 62%至 98%之间,与用于囊泡形成的成分(如磷脂和表面活性剂)的浓度无关。只有含有 30mg/mL 表面活性剂的非离子型脂质体显示出稍低的封装百分比。关于粒径分布,确定的非离子型脂质体、脂质体和转脂体的值分别为 0.82±0.09μm、1.66±0.21μm 和 0.55±0.06μm。重要的是,在 4°C 下储存 6 个月期间,所有三种类型的纳米囊泡都保持了噬菌体的感染力,除了含有低浓度成分的脂质体外。此外,我们观察到非离子型脂质体部分保护了噬菌体颗粒免受低 pH 的影响。因此,虽然游离的 phiIPLA-RODI 在 pH 4.5 孵育 60 分钟后不可检测,但封装在非离子型脂质体中的噬菌体的效价仅下降了 2 个对数单位。总体而言,我们的结果表明,封装是提高噬菌体稳定性和抗菌功效的一种合适方法,从而可将其应用于食品加工行业。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b7e/6163856/f8162662d17f/viruses-10-00495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b7e/6163856/f8162662d17f/viruses-10-00495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b7e/6163856/f8162662d17f/viruses-10-00495-g001.jpg

相似文献

1
Strategies to Encapsulate the Bacteriophage phiIPLA-RODI.噬菌体 phiIPLA-RODI 的包封策略。
Viruses. 2018 Sep 13;10(9):495. doi: 10.3390/v10090495.
2
Comparative analysis of different preservation techniques for the storage of Staphylococcus phages aimed for the industrial development of phage-based antimicrobial products.比较不同保存技术对用于开发噬菌体抗菌产品的工业用噬菌体的保存效果。
PLoS One. 2018 Oct 11;13(10):e0205728. doi: 10.1371/journal.pone.0205728. eCollection 2018.
3
Optimizing Propagation of Staphylococcus aureus Infecting Bacteriophage vB_SauM-phiIPLA-RODI on Staphylococcus xylosus Using Response Surface Methodology.利用响应面法优化感染葡萄球菌噬菌体 vB_SauM-phiIPLA-RODI 在木糖葡萄球菌上的繁殖。
Viruses. 2018 Mar 27;10(4):153. doi: 10.3390/v10040153.
4
Study of the Interactions Between Bacteriophage phiIPLA-RODI and Four Chemical Disinfectants for the Elimination of Staphylococcus aureus Contamination.噬菌体 phiIPLA-RODI 与四种化学消毒剂相互作用研究,以消除金黄色葡萄球菌污染。
Viruses. 2018 Feb 28;10(3):103. doi: 10.3390/v10030103.
5
The Behavior of Staphylococcus aureus Dual-Species Biofilms Treated with Bacteriophage phiIPLA-RODI Depends on the Accompanying Microorganism.用噬菌体phiIPLA-RODI处理的金黄色葡萄球菌双物种生物膜的行为取决于伴随的微生物。
Appl Environ Microbiol. 2017 Jan 17;83(3). doi: 10.1128/AEM.02821-16. Print 2017 Feb 1.
6
Two Phages, phiIPLA-RODI and phiIPLA-C1C, Lyse Mono- and Dual-Species Staphylococcal Biofilms.两种噬菌体phiIPLA-RODI和phiIPLA-C1C可裂解单菌种和双菌种葡萄球菌生物膜。
Appl Environ Microbiol. 2015 May 15;81(10):3336-48. doi: 10.1128/AEM.03560-14. Epub 2015 Mar 6.
7
Synergistic action of phage phiIPLA-RODI and lytic protein CHAPSH3b: a combination strategy to target Staphylococcus aureus biofilms.噬菌体phiIPLA - RODI与裂解蛋白CHAPSH3b的协同作用:一种靶向金黄色葡萄球菌生物膜的联合策略。
NPJ Biofilms Microbiomes. 2021 Apr 22;7(1):39. doi: 10.1038/s41522-021-00208-5.
8
Impact of the calcium concentration on the efficacy of phage phiIPLA-RODI, LysRODIΔAmi and nisin for the elimination of Staphylococcus aureus during lab-scale cheese production.钙浓度对噬菌体 phiIPLA-RODI、LysRODIΔAmi 和乳链菌肽在实验室规模奶酪生产中消除金黄色葡萄球菌效果的影响。
Int J Food Microbiol. 2023 Aug 16;399:110227. doi: 10.1016/j.ijfoodmicro.2023.110227. Epub 2023 Apr 29.
9
Environmental pH is a key modulator of Staphylococcus aureus biofilm development under predation by the virulent phage phiIPLA-RODI.环境 pH 值是金黄色葡萄球菌生物膜发育的关键调节剂,在受毒性噬菌体 phiIPLA-RODI 捕食时更是如此。
ISME J. 2021 Jan;15(1):245-259. doi: 10.1038/s41396-020-00778-w. Epub 2020 Sep 22.
10
Low-level predation by lytic phage phiIPLA-RODI promotes biofilm formation and triggers the stringent response in Staphylococcus aureus.溶菌噬菌体 phiIPLA-RODI 的低级捕食作用促进金黄色葡萄球菌生物膜的形成并引发严格反应。
Sci Rep. 2017 Jan 19;7:40965. doi: 10.1038/srep40965.

引用本文的文献

1
Phage/nanoparticle cocktails for a biocompatible and environmentally friendly antibacterial therapy.用于生物相容性和环境友好型抗菌治疗的噬菌体/纳米颗粒鸡尾酒制剂
Appl Microbiol Biotechnol. 2025 May 29;109(1):129. doi: 10.1007/s00253-025-13526-x.
2
Phage therapeutic delivery methods and clinical trials for combating clinically relevant pathogens.用于对抗临床相关病原体的噬菌体治疗递送方法及临床试验。
Ther Deliv. 2025 Mar;16(3):247-269. doi: 10.1080/20415990.2024.2426824. Epub 2024 Nov 15.
3
Comprehensive retrospect and future perspective on bacteriophage and cancer.

本文引用的文献

1
The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2016.欧盟2016年人畜共患病、人畜共患病原体及食源性疾病暴发的趋势与来源总结报告
EFSA J. 2017 Dec 12;15(12):e05077. doi: 10.2903/j.efsa.2017.5077. eCollection 2017 Dec.
2
Microfluidic-assisted bacteriophage encapsulation into liposomes.微流控辅助噬菌体包封入脂质体。
Int J Pharm. 2018 Jul 10;545(1-2):176-182. doi: 10.1016/j.ijpharm.2018.04.063. Epub 2018 May 2.
3
Current Demands for Food-Approved Liposome Nanoparticles in Food and Safety Sector.
噬菌体与癌症的全面回顾与未来展望
Virol J. 2024 Nov 6;21(1):278. doi: 10.1186/s12985-024-02553-1.
4
Isolation and encapsulation of bacteriophage with chitosan nanoparticles for biocontrol of multidrug-resistant methicillin-resistant Staphylococcus aureus isolated from broiler poultry farms.壳聚糖纳米粒分离和包封噬菌体对肉鸡养殖场分离的耐多药耐甲氧西林金黄色葡萄球菌的生物防治。
Sci Rep. 2024 Feb 26;14(1):4702. doi: 10.1038/s41598-024-55114-5.
5
Phages and Nanotechnology: New Insights against Multidrug-Resistant Bacteria.噬菌体与纳米技术:对抗多重耐药细菌的新见解
Biodes Res. 2023 Jan 16;5:0004. doi: 10.34133/bdr.0004. eCollection 2023.
6
Bacteriophage Delivery Systems for Food Applications: Opportunities and Perspectives.用于食品应用的噬菌体输送系统:机遇与展望。
Viruses. 2023 May 29;15(6):1271. doi: 10.3390/v15061271.
7
Eudragit FS Microparticles Containing Bacteriophages, Prepared by Spray-Drying for Oral Administration.含噬菌体的Eudragit FS微粒,通过喷雾干燥法制备用于口服给药。
Pharmaceutics. 2023 May 27;15(6):1602. doi: 10.3390/pharmaceutics15061602.
8
An Edible Biopolymeric Microcapsular Wrapping Integrating Lytic Bacteriophage Particles for : Potential for Integration into Poultry Feed.一种整合裂解性噬菌体颗粒的可食用生物聚合物微胶囊包裹物:整合到家禽饲料中的潜力。
Antibiotics (Basel). 2023 May 31;12(6):988. doi: 10.3390/antibiotics12060988.
9
Drug delivery strategies for antibiofilm therapy.抗生物膜治疗的药物传递策略。
Nat Rev Microbiol. 2023 Sep;21(9):555-572. doi: 10.1038/s41579-023-00905-2. Epub 2023 May 31.
10
Statistical optimization of a podoviral anti-MRSA phage CCASU-L10 generated from an under sampled repository: Chicken rinse.从抽样不足的鸡冲洗液中生成的抗耐甲氧西林金黄色葡萄球菌噬菌体 CCASU-L10 的统计优化。
Front Cell Infect Microbiol. 2023 Mar 31;13:1149848. doi: 10.3389/fcimb.2023.1149848. eCollection 2023.
食品和安全领域对食品批准的脂质体纳米颗粒的当前需求。
Front Microbiol. 2017 Dec 5;8:2398. doi: 10.3389/fmicb.2017.02398. eCollection 2017.
4
Encapsulation of Listeria Phage A511 by Alginate to Improve Its Thermal Stability.利用海藻酸盐包裹李斯特菌噬菌体A511以提高其热稳定性。
Methods Mol Biol. 2018;1681:89-95. doi: 10.1007/978-1-4939-7343-9_7.
5
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.噬菌体的制剂学、稳定性和包封用于噬菌体治疗。
Adv Colloid Interface Sci. 2017 Nov;249:100-133. doi: 10.1016/j.cis.2017.05.014. Epub 2017 May 14.
6
Phospholipid vesicles encapsulated bacteriophage: A novel approach to enhance phage biodistribution.磷脂囊泡包裹的噬菌体:一种增强噬菌体生物分布的新方法。
J Virol Methods. 2016 Oct;236:68-76. doi: 10.1016/j.jviromet.2016.07.002. Epub 2016 Jul 5.
7
Bacteriophages as Weapons Against Bacterial Biofilms in the Food Industry.噬菌体作为对抗食品工业中细菌生物膜的武器
Front Microbiol. 2016 Jun 8;7:825. doi: 10.3389/fmicb.2016.00825. eCollection 2016.
8
Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia-Reperfusion Injury.脂质体包裹的抗坏血酸:对维生素C生物利用度及预防缺血再灌注损伤能力的影响
Nutr Metab Insights. 2016 Jun 20;9:25-30. doi: 10.4137/NMI.S39764. eCollection 2016.
9
Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies.噬菌体包裹于脂质体中可增强其进入巨噬细胞的能力并使其免受中和抗体的影响。
PLoS One. 2016 Apr 26;11(4):e0153777. doi: 10.1371/journal.pone.0153777. eCollection 2016.
10
The potential of the endolysin Lysdb from Lactobacillus delbrueckii phage for combating Staphylococcus aureus during cheese manufacture from raw milk.德氏乳杆菌噬菌体的内溶素Lysdb在生乳奶酪制作过程中对抗金黄色葡萄球菌的潜力。
Appl Microbiol Biotechnol. 2016 Apr;100(8):3545-54. doi: 10.1007/s00253-015-7185-x. Epub 2015 Dec 1.